Douglas Leedy is a Cardiology physician affiliated with University of Washington. OpenAlex indexes 21 publications with 496 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 17th Ave Fl 6
Seattle, WA 981225788
Telephone
206-215-4545Provider last certified this registry record 24 Feb 2026.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BridgeBio Pharma, Inc.Program year20251 payment
- Amgen Inc.Program year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.8%Beta blocker19.9%Metoprolol Succinate72%Carvedilol28%Part D≥102 patientsStatin16.7%Atorvastatin Calcium60%Rosuvastatin Calcium35%Pravastatin Sodium5%Part D<11 patients+ 11 more classes in this area
Blood & clotting
15.4%Factor Xa inhibitor13.3%Eliquis80%Xarelto20%Part D≥72 patientsP2Y12 inhibitor2%Clopidogrel100%Part D≥16 patientsMetabolism & gastrointestinal
8%SGLT2 inhibitor4.7%Jardiance100%Part D≥37 patientsPotassium supplement2.5%Potassium Chloride100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Can Outpatient Worsening Heart Failure Serve as an Endpoint in Clinical Trials of Transthyretin Amyloidosis?
Journal of the American College of Cardiology
2025 - Evolving Cardioprotective Strategies in Cardio-Oncology: A Narrative Review
Current Cardiology Reports
2025 - Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
Journal of the American Heart Association
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”